The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

Details of the new rules for COVID-19 vaccine approvals were also outlined in an article published by The New England Journal ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

A vaccine that helps people overcome cocaine addiction has shown signs of being safe and effective in a small trial ...

The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.